High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells. [electronic resource]
Producer: 19970227Description: 131-41 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Purging
- Bone Marrow Transplantation -- mortality
- Child
- Child, Preschool
- Clinical Trials as Topic
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Graft Survival
- Hematopoietic Cell Growth Factors -- pharmacology
- Hematopoietic Stem Cell Transplantation
- Humans
- Life Tables
- Lymphoma -- drug therapy
- Male
- Middle Aged
- Prospective Studies
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous
- Treatment Outcome
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.